News in the Life Sciences Industry

BASEL, Switzerland, Jan. 7, 2020 /PRNewswire/ -- VectivBio, a clinical-stage biotechnology company bringing transformational medicines to patients... Read more ››

ABBOTT PARK, Ill., Jan. 7, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott's HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery. The... Read more ››

NEW YORK and SANTA FE, N.M., Jan. 7, 2020 /PRNewswire/ -- Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye's pioneering Orion computational platform into Redesign's drug discovery platform.

SINGAPORE, Jan. 6, 2020 /CNW/ -- Mundipharma has announced today that it has sealed an exclusive sales agreement with Biosolution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-generation autologous chondrocyte implantation product, CartiLife(®).

Not intended for US-, Canada- and UK-based media

MARLBOROUGH, Mass., Dec. 27, 2019 /PRNewswire/ -- BTL Aesthetics ("BTL"), a leading manufacturer of non-invasive technologies for body shaping, announced today that its U.S. affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany,... Read more ››

STOCKHOLM, Dec. 21, 2019 /PRNewswire/ -- The Swedish company BraineHealth that is developing automation tools for healthcare using AI methods launched a free humanitarian Medipacker education program.

LAVAL, Quebec and HEIDELBERG, Germany, Dec. 20, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, and Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics,... Read more ››

SAN ANTONIO, Dec. 19, 2019 /PRNewswire/ -- Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical... Read more ››

SINGAPORE, Dec. 19, 2019 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of innovative cell therapies to treat cancer, today announced plans to open a 90,000 square foot commercial-scale cell therapy manufacturing facility... Read more ››

- Gives scientists a new view into natural cell activity, accelerating drug development